Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,758,013
Closed -$90.1M 68
2022
Q4
$90.1M Hold
1,758,013
3.45% 5
2022
Q3
$76.9M Buy
1,758,013
+140,816
+9% +$6.84M 3.05% 7
2022
Q2
$84.8M Buy
1,617,197
+291,167
+22% +$14.8M 3.23% 6
2022
Q1
$68.6M Buy
1,326,030
+10,410
+0.8% +$540K 2.37% 11
2021
Q4
$77.7M Buy
1,315,620
+947,981
+258% +$47M 2.46% 9
2021
Q3
$15.8M Buy
+367,639
New +$16.3M 0.58% 53
2020
Q3
Sell
-63,851
Closed -$1.98M 65
2020
Q2
$1.98M Buy
63,851
+10,043
+19% +$341K 0.13% 61
2020
Q1
$1.67M Hold
53,808
0.13% 58
2019
Q4
$2M Hold
53,808
0.12% 62
2019
Q3
$1.83M Hold
53,808
0.06% 67
2019
Q2
$2.21M Hold
53,808
0.07% 70
2019
Q1
$2.17M Hold
53,808
0.08% 70
2018
Q4
$2.23M Hold
53,808
0.09% 69
2018
Q3
$2.25M Hold
53,808
0.08% 72
2018
Q2
$1.85M Hold
53,808
0.07% 76
2018
Q1
$1.81M Hold
53,808
0.08% 73
2017
Q4
$1.85M Hold
53,808
0.08% 76
2017
Q3
$1.82M Hold
53,808
0.09% 73
2017
Q2
$1.72M Sell
53,808
-223,338
-81% -$7.04M 0.09% 72
2017
Q1
$8.99M Sell
277,146
-273,372
-50% -$8.62M 0.46% 49
2016
Q4
$17M Sell
550,518
-262,659
-32% -$8.02M 0.92% 21
2016
Q3
$26.1M Hold
813,177
1.95% 6
2016
Q2
$27.2M Hold
813,177
3.31% 4
2016
Q1
$22.9M Buy
813,177
+125,566
+18% +$3.59M 2.6% 9
2015
Q4
$21.1M Sell
687,611
-52,037
-7% -$1.64M 2.44% 14
2015
Q3
$22M Sell
739,648
-16,443
-2% -$527K 2.71% 8
2015
Q2
$24.1M Buy
756,091
+703,444
+1,336% +$22.9M 2.61% 6
2015
Q1
$1.74M Hold
52,647
0.18% 57
2014
Q4
$1.56M Hold
52,647
0.16% 54
2014
Q3
$1.48M Sell
52,647
-488,319
-90% -$13.7M 0.17% 50
2014
Q2
$15.2M Sell
540,966
-266,799
-33% -$7.61M 1.9% 17
2014
Q1
$24.6M Buy
807,765
+79,841
+11% +$2.38M 2.98% 4
2013
Q4
$21.2M Buy
727,924
+159,159
+28% +$4.63M 2.71% 4
2013
Q3
$15.5M Hold
568,765
2.25% 12
2013
Q2
$15.1M Buy
+568,765
New +$15.7M 2.4% 10

Other funds holding PFE

Wafra Inc's PFE Position: Q1 2023 in Review

Wafra Inc sold out of Pfizer (PFE) in Q1 2023, closing a stake of 1,758,013 shares — an estimated $90.1M sold.

Wafra Inc first reported a position in PFE in Q2 2013 and held it in 35 quarters. The position peaked at $90.1M in Q4 2022. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Wafra Inc reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Wafra Inc sold 1,758,013 Pfizer shares in Q1 2023, an estimated $90.1M.
  • Wafra Inc first reported a position in Pfizer in Q2 2013 and held it in 35 quarters.
  • Wafra Inc's Pfizer position peaked at $90.1M in Q4 2022.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Wafra Inc's 13F filing for Q1 2023, filed 4 May 2023.